CAMDA 2014 - 13th International Conference on the Critical Assessment of Massive Data Analysis
Date2014-07-11 - 2014-07-12
Deadline2014-05-25
VenueBoston, USA - United States
Keywords
Websitehttps://www.camda.info
Topics/Call fo Papers
The 13th CAMDA conference will be held in Boston, United States from Friday, July 11 through Saturday, July 12, 2014. As in recent years, CAMDA runs as a Satellite Meeting of the Annual International Conference on Intelligent Systems for Molecular Biology (ISMB).
Currently, the Big Data explosion is the grand challenge in life sciences. Analyzing large data sets is emerging to one of the scientific key techniques in the post genomic era. Still the data analysis bottleneck prevents new biotechnologies from providing new medical and biological insights in a larger scale. This trend towards the need for analyzing massive data sets is further accelerated by novel high throughput sequencing technologies and the increasing size of biomedical studies. CAMDA focuses on the analysis and integration of the massive data sets in life sciences. It provides new approaches and solutions to the big data problem, presents new techniques in the field of bioinformatics, data analysis, and statistics for handling and processing large data sets.
CAMDA focuses on the specific challenges and opportunities in the analysis of the massive data sets that are increasingly produced in several fields of the life sciences. The conference offers researchers from the computer sciences, statistics, molecular biology, and other fields a unique opportunity to benefit from a critical comparative evaluation of the latest approaches in the analysis of life sciences' “Big Data”.
This year, CAMDA's scientific committee set up three challenges to integrate multi-track -omics data:
dual dose response profiles for 14 unknown and 2 known compounds from the InnoMed PredTox project of the EU FP7 program;
selected cancers from International Cancer Genome Consortium (ICGC), and;
the prediction of drug compatibility from an extremely large toxicogenomic data set.
Leading scientists from around the world are selected to present their analyses in talks, complemented by poster sessions. Papers based on the submitted extended abstracts submitted for presentation at the meeting are published in the conference proceedings. Starting with 2012, CAMDA has entered a partnership with Landes Biosciences, publishing the CAMDA Proceedings as an open access PubMed indexed special issue of Systems Biomedicine. As in last years, there will be prizes for the best contributed analysis / presentations. The three prize winners will receive a free one-year subscription to F1000Prime (worth $250) and a free submission to F1000Research (worth $1000). The first prize winner will additionally receive the prestigious CAMDA award.
Currently, the Big Data explosion is the grand challenge in life sciences. Analyzing large data sets is emerging to one of the scientific key techniques in the post genomic era. Still the data analysis bottleneck prevents new biotechnologies from providing new medical and biological insights in a larger scale. This trend towards the need for analyzing massive data sets is further accelerated by novel high throughput sequencing technologies and the increasing size of biomedical studies. CAMDA focuses on the analysis and integration of the massive data sets in life sciences. It provides new approaches and solutions to the big data problem, presents new techniques in the field of bioinformatics, data analysis, and statistics for handling and processing large data sets.
CAMDA focuses on the specific challenges and opportunities in the analysis of the massive data sets that are increasingly produced in several fields of the life sciences. The conference offers researchers from the computer sciences, statistics, molecular biology, and other fields a unique opportunity to benefit from a critical comparative evaluation of the latest approaches in the analysis of life sciences' “Big Data”.
This year, CAMDA's scientific committee set up three challenges to integrate multi-track -omics data:
dual dose response profiles for 14 unknown and 2 known compounds from the InnoMed PredTox project of the EU FP7 program;
selected cancers from International Cancer Genome Consortium (ICGC), and;
the prediction of drug compatibility from an extremely large toxicogenomic data set.
Leading scientists from around the world are selected to present their analyses in talks, complemented by poster sessions. Papers based on the submitted extended abstracts submitted for presentation at the meeting are published in the conference proceedings. Starting with 2012, CAMDA has entered a partnership with Landes Biosciences, publishing the CAMDA Proceedings as an open access PubMed indexed special issue of Systems Biomedicine. As in last years, there will be prizes for the best contributed analysis / presentations. The three prize winners will receive a free one-year subscription to F1000Prime (worth $250) and a free submission to F1000Research (worth $1000). The first prize winner will additionally receive the prestigious CAMDA award.
Other CFPs
- Interdisciplinary Coups to Calamities
- First International Workshop on Social Deliberative Skills in Online Environments
- International Conference on Principles of Distributed Systems
- 48th International Conference of the Architectural Science Association (ANZAScA)
- The European Network of Living Labs 5th Summer School
Last modified: 2014-03-06 22:49:13